Compare Cudis (CUDIS) vs Injective (INJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cudis vs Injective — how do they compare? Cudis trades at Rp19.03 (market cap Rp4,68M, Rp7,12M 24h volume), while Injective trades at Rp76,667 (market cap Rp7,62T, Rp1,02T 24h volume). The key difference: Injective is far larger — about 1628205.1× Cudis's market cap, and Cudis's supply is capped (247,5M / 1B CUDIS (25%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Cudis for 11 Days and Injective for 37 Days on average.
| CUDIS | INJ | |
|---|---|---|
Market Cap | Rp4,68M | Rp7,62T |
Volume (24h) | Rp7,12M | Rp1,02T |
Circulating Supply | 247,5M / 1B CUDIS (25%) | 100M INJ |
Typical Hold Time | 11 Days | 37 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cudis is trading at Rp19.346 with a market cap of Rp4.78M, showing bearish technical signals with 13 sell signals in moving averages. The token has limited circulation at 25% of max supply and short average hold time of 11 days. Current price sits near key support levels with RSI indicators suggesting potential oversold conditions. No recent protocol updates or ecosystem developments were identified.
Overall outlook remains cautious due to strong bearish technical signals and limited market depth. Key opportunity lies in potential oversold bounce from support levels, while major risks include low liquidity, high volatility, and the token's early adoption stage. Investors should monitor for increased trading volume and network activity.
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cudis
CUDIS is creating the first-ever Longevity Protocol aimed at making longevity trackable, personalized, and rewarding. By integrating the CUDIS Ring, an AI-powered Longevity Hub, and a blockchain-driven Super App, users will have complete ownership of their health data, receive real-time insights on their longevity, and gain economic incentives for optimizing their biological health. CUDIS is building a new ecosystem for longevity that includes realistic and effective products, programs, and services, in collaboration with partners around the world.
Read more on CUDIS →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
